232 related articles for article (PubMed ID: 15936014)
1. Centrally-mediated antinociceptive actions of GABA(A) receptor agonists in the rat spared nerve injury model of neuropathic pain.
Rode F; Jensen DG; Blackburn-Munro G; Bjerrum OJ
Eur J Pharmacol; 2005 Jun; 516(2):131-8. PubMed ID: 15936014
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the novel subtype-selective GABAA receptor-positive allosteric modulator NS11394 [3'-[5-(1-hydroxy-1-methyl-ethyl)-benzoimidazol-1-yl]-biphenyl-2-carbonitrile] with diazepam, zolpidem, bretazenil, and gaboxadol in rat models of inflammatory and neuropathic pain.
Munro G; Lopez-Garcia JA; Rivera-Arconada I; Erichsen HK; Nielsen EØ; Larsen JS; Ahring PK; Mirza NR
J Pharmacol Exp Ther; 2008 Dec; 327(3):969-81. PubMed ID: 18791060
[TBL] [Abstract][Full Text] [Related]
3. Amygdala GABA-A receptor involvement in mediating sensory-discriminative and affective-motivational pain responses in a rat model of peripheral nerve injury.
Pedersen LH; Scheel-Krüger J; Blackburn-Munro G
Pain; 2007 Jan; 127(1-2):17-26. PubMed ID: 16965855
[TBL] [Abstract][Full Text] [Related]
4. The importance of genetic background on pain behaviours and pharmacological sensitivity in the rat spared serve injury model of peripheral neuropathic pain.
Rode F; Thomsen M; Broløs T; Jensen DG; Blackburn-Munro G; Bjerrum OJ
Eur J Pharmacol; 2007 Jun; 564(1-3):103-11. PubMed ID: 17383631
[TBL] [Abstract][Full Text] [Related]
5. Gaboxadol -- a different hypnotic profile with no tolerance to sleep EEG and sedative effects after repeated daily dosing.
Ebert B; Anderson NJ; Cremers TI; Rasmussen S; Vogel V; Fahey JM; Sánchez C
Pharmacol Biochem Behav; 2008 Jul; 90(1):113-22. PubMed ID: 18304623
[TBL] [Abstract][Full Text] [Related]
6. Antinociceptive activity of α4β2* neuronal nicotinic receptor agonist A-366833 in experimental models of neuropathic and inflammatory pain.
Nirogi R; Jabaris SL; Jayarajan P; Abraham R; Shanmuganathan D; Rasheed MA; Royapalley PK; Goura V
Eur J Pharmacol; 2011 Oct; 668(1-2):155-62. PubMed ID: 21756895
[TBL] [Abstract][Full Text] [Related]
7. Spinal administration of a delta opioid receptor agonist attenuates hyperalgesia and allodynia in a rat model of neuropathic pain.
Holdridge SV; Cahill CM
Eur J Pain; 2007 Aug; 11(6):685-93. PubMed ID: 17175187
[TBL] [Abstract][Full Text] [Related]
8. Behavioural effects of the novel AMPA/GluR5 selective receptor antagonist NS1209 after systemic administration in animal models of experimental pain.
Blackburn-Munro G; Bomholt SF; Erichsen HK
Neuropharmacology; 2004 Sep; 47(3):351-62. PubMed ID: 15275824
[TBL] [Abstract][Full Text] [Related]
9. Antiallodynic effects of NMDA glycine(B) antagonists in neuropathic pain: possible peripheral mechanisms.
Christoph T; Reissmüller E; Schiene K; Englberger W; Chizh BA
Brain Res; 2005 Jun; 1048(1-2):218-27. PubMed ID: 15922311
[TBL] [Abstract][Full Text] [Related]
10. GABAA receptor modulation in dorsal root ganglia in vivo affects chronic pain after nerve injury.
Naik AK; Pathirathna S; Jevtovic-Todorovic V
Neuroscience; 2008 Jul; 154(4):1539-53. PubMed ID: 18554816
[TBL] [Abstract][Full Text] [Related]
11. Gaboxadol, a selective extrasynaptic GABA(A) agonist, does not generalise to other sleep-enhancing drugs: a rat drug discrimination study.
McDonald LM; Sheppard WF; Staveley SM; Sohal B; Tattersall FD; Hutson PH
Neuropharmacology; 2007 Mar; 52(3):844-53. PubMed ID: 17196996
[TBL] [Abstract][Full Text] [Related]
12. GABA(A) agonists and partial agonists: THIP (Gaboxadol) as a non-opioid analgesic and a novel type of hypnotic.
Krogsgaard-Larsen P; Frølund B; Liljefors T; Ebert B
Biochem Pharmacol; 2004 Oct; 68(8):1573-80. PubMed ID: 15451401
[TBL] [Abstract][Full Text] [Related]
13. A role for cannabinoid receptors, but not endogenous opioids, in the antinociceptive activity of the CB2-selective agonist, GW405833.
Whiteside GT; Gottshall SL; Boulet JM; Chaffer SM; Harrison JE; Pearson MS; Turchin PI; Mark L; Garrison AE; Valenzano KJ
Eur J Pharmacol; 2005 Dec; 528(1-3):65-72. PubMed ID: 16316650
[TBL] [Abstract][Full Text] [Related]
14. Antinociceptive effects of the antidepressants amitriptyline, duloxetine, mirtazapine and citalopram in animal models of acute, persistent and neuropathic pain.
Bomholt SF; Mikkelsen JD; Blackburn-Munro G
Neuropharmacology; 2005 Feb; 48(2):252-63. PubMed ID: 15695164
[TBL] [Abstract][Full Text] [Related]
15. GABAA receptors in the central nucleus of amygdala (CeA) affect on pain modulation.
Hasanein P; Mirazi N; Javanmardi K
Brain Res; 2008 Nov; 1241():36-41. PubMed ID: 18838064
[TBL] [Abstract][Full Text] [Related]
16. Role of spinal gamma-aminobutyric acidA receptors in formalin-induced nociception in the rat.
Kaneko M; Hammond DL
J Pharmacol Exp Ther; 1997 Aug; 282(2):928-38. PubMed ID: 9262360
[TBL] [Abstract][Full Text] [Related]
17. The antihyperalgesic effect of cytidine-5'-diphosphate-choline in neuropathic and inflammatory pain models.
Bagdas D; Sonat FA; Hamurtekin E; Sonal S; Gurun MS
Behav Pharmacol; 2011 Sep; 22(5-6):589-98. PubMed ID: 21836465
[TBL] [Abstract][Full Text] [Related]
18. Analgesic properties of the novel compound M43068 in rat models of acute and neuropathic pain.
Akada Y; Mori R; Kato Y; Yamasaki F; Mochizuki H
Eur J Pharmacol; 2005 Oct; 523(1-3):46-53. PubMed ID: 16226249
[TBL] [Abstract][Full Text] [Related]
19. The roles of different subtypes of opioid receptors in mediating the nucleus submedius opioid-evoked antiallodynia in a neuropathic pain model of rats.
Wang JY; Zhao M; Yuan YK; Fan GX; Jia H; Tang JS
Neuroscience; 2006; 138(4):1319-27. PubMed ID: 16472929
[TBL] [Abstract][Full Text] [Related]
20. Local peripheral antinociceptive effects of 14-O-methyloxymorphone derivatives in inflammatory and neuropathic pain in the rat.
Obara I; Makuch W; Spetea M; Schütz J; Schmidhammer H; Przewlocki R; Przewlocka B
Eur J Pharmacol; 2007 Mar; 558(1-3):60-7. PubMed ID: 17204264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
